enzyme replacement therapy
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy.
... to enzyme replacement ...to enzyme replacement therapy, and 8 of 11 treated patients scored negative for Fabry disease in the diagnostic ...to enzyme replacement ...
9
Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI
... Enzyme replacement therapy with galsulfase in the prescribed dos- age of 1 mg/kg body weight IV weekly has shown to be safe and effective in slowing progression and/or improving the burden of the ...
8
Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
... Mucopolysaccharidosis type I (MPS I) is a rare lysosomal disorder caused by deficiency of alpha-L-iduronidase. Few clinical trials have assessed the effect of enzyme replacement therapy (ERT) for ...
7
Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
... degradation. Enzyme Replacement Therapy (ERT) has been shown to reduce accumulation and urinary excretion of GAG, and to improve some of the patients' clinical ...restriction enzyme tests and ...
6
Avaliação clínico-laboratorial dos pacientes com mucopolissacaridose tipos I,II e...
... the enzyme arylsulfatase B, which is encoded by the ARSB ...with enzyme replacement therapy (ERT) for MPS VI improves the clinical status of and generates hope for MPS VI ...
155
J. Pediatr. (Rio J.) vol.85 número3 en v85n3a12
... underwent enzyme replacement therapy or not, there was statistically signiicant difference in oral breathing mode (more frequent in the group without enzyme replacement ...
7
Arq. NeuroPsiquiatr. vol.64 número3B
... ABSTRACT - Purpose: To report the clinical and neuroimaging, central nervous system (CNS) findings of patients with Fabry disease (FD) during 24 months of enzyme replacement therapy (ERT) with ...
7
J. bras. pneumol. vol.43 número5
... pancreatic enzyme replacement therapy, multivitamin supplement (vitamins A, D, E, and K) intake, and a hypercaloric diet (a diet high in energy, protein, and fat, based on a nutritional care plan and ...
7
Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease.
... beta-glucocerebrosidase enzyme replacement therapy approved in the United States, Israel, and other countries for treatment of Type 1 Gaucher disease in adults, and is the first approved plant ...
10
J. Pediatr. (Rio J.) vol.84 número4 suppl. en v84n4s0a03
... The majority of lysosomal diseases are caused by the pres- ence of pathogenic mutations to genes that code for enzymes that act within lysosomes (acidic hydrolases), whereas the majority of peroxisomal diseases are ...
12
Arq. Gastroenterol. vol.53 número2
... pancreatic enzyme and the enzyme replacement cost in post pancreatectomy patients with and without chronic ...of enzyme replacement therapy were included in this ...of ...
4
Model for Quantitative Evaluation of Enzyme Replacement Treatment
... Its enzyme replacement treatment was the new progress of modern biotechnology, successfully used in the last ...The enzyme replacement is the most expensive ...the enzyme ...
8
(São Paulo, online) vol.1 número6
... Cognitive Behavioral Therapy protocol: the first phase First session . Initial questions: Why do you smoke? How does it affect your health? Points to be made: the harm caused by tobacco, its disease-causing ...
5
transdermal hormone replacement therapy for relieving menopausal symptoms : a confocal Raman spectroscopy study
... The severity of postmenopausal symptoms was evaluated by the form submitted after each 6 months of the study. Satisfaction with the transdermal hormone therapy was also evaluated at those times. Compliance with ...
8
PDF EN Jornal Brasileiro de Pneumologia 10 10 english
... described. In our experience, we believe there is also an association between severe asthma and congenital agammaglobulinemia, common variable immunodeficiency and specific polysac- charide antibody deficiency with ...
10
Hormone replacement therapy in menopause as a risk factor for developing breast cancer
... Because it is a very specific theme did not, there was great variety in the thematic areas, Table 3. The thematic area that got more work was precisely hormone replacement therapy and the risk for ...
11
J. bras. pneumol. vol.35 número10 en v35n10a10
... described. In our experience, we believe there is also an association between severe asthma and congenital agammaglobulinemia, common variable immunodeficiency and specific polysac- charide antibody deficiency with ...
10
Prospects and Consequences of Hormone Replacement Therapy in Cancers A Review
... As showed in PEPI trial, estrogen increased endometrial hyperplasia at rate of 10% per year. [19] Pike et al. presented data which showed that both the cyclic and continuous hormone replacement regimens are ...
5
Biolipídio B2: desenvolvimento de um veículo estável para reposição hormonal transdérmica nanoestruturada
... The hormone administration by the oral route is frequently related with different many side effects. The aim of this study was to evaluate the safety and efficacy of a new product intended to transdermal hormone ...
96
J. Bras. Nefrol. vol.39 número3
... Keywords: dialysis; renal dialysis; palliative care; bioethics; acute kidney injury; renal replacement therapy; geriatrics; medical futility; withholding treatment; kidney failure, [r] ...
11